NVONOVO NORDISK A S

NYSE novonordisk.com


$ 142.42 $ 3.50 (2.52 %)    

Friday, 05-Jul-2024 15:59:58 EDT
QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 142.37
$ 140.85
$ 0.00 x 0
$ 149.00 x 100
$ 140.51 - $ 142.86
$ 74.66 - $ 148.15
3,664,490
na
642,089
$ 0.64
$ 0.00
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 glp-1-treatments-such-as-wegvoy-mounjaro-cut-obesity-related-cancer-risks-study-finds

A study finds that GLP-1 treatments, including Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, significantly reduce th...

 ozempic-maker-novo-nordisk-reprimanded-by-uk-regulators-for-payment-disclosure-failures

UK regulators reprimand Novo Nordisk for failing to disclose nearly $10 million in fees and expenses. The PMCPA cites breaches ...

Core News & Articles

https://news.bloomberglaw.com/health-law-and-business/ozempic-may-lower-risk-of-obesity-related-cancers-study-finds

 sp-500-nasdaq-100-climb-to-record-highs-as-data-fosters-rate-cut-optimism-ahead-of-fed-minutes-gold-bonds-rally-whats-driving-markets-wednesday

The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for...

 using-obesity-drugs-potential-vision-loss-disorder-linked-to-novo-nordisks-ozempic-and-wegovy-study-finds

New study suggests a potential link between Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, and NAION, a condition that can...

Core News & Articles

https://www.statnews.com/2024/07/03/ozempic-wegovy-naion-vision-loss-study/A new observational study on Wednesday reported for ...

Core News & Articles

https://nypost.com/2024/07/03/lifestyle/potential-link-between-ozempic-wegovy-and-serious-eye-condition-study/Researchers say t...

 joe-biden-suggests-novo-nordisk-eli-lilly-to-lower-prices-for-its-popular-obesity-drugs

American leaders push for lower drug prices, highlighting recent legislation and widespread support for affordable medications....

Core News & Articles

- Reuters

Core News & Articles

https://www.usatoday.com/story/opinion/2024/07/02/biden-sanders-prescription-drug-cost-ozempic-wegovy/74232827007/

 cantor-fitzgerald-reiterates-overweight-on-novo-nordisk-maintains-160-price-target

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:NVO) with a Overweight and maintains $160 price target.

 novo-nordisk-buys-2seventys-hemophilia-a-program-divestiture-supports-exclusive-focus-on-abecma

2seventy Bio finalized an asset purchase agreement with Novo Nordisk involving the Hemophilia A program and in vivo gene editin...

 volkswagen-puts-our-rivian-bet-in-the-black-the-pros-and-cons-of-trading-options-versus-stocks

Novo Nordisk, Carvana, And Now Rivian  We've had bullish moves in three stocks we had bullish bets on this week, and since...

 novo-nordisk-to-restrict-initial-wegovy-sales-in-china-amid-high-demand

Novo Nordisk will limit initial sales of Wegovy in China to manage global supply and address the rising obesity rates in the wo...

 hims--hers-health-stock-is-sliding-thursday-whats-going-on

Hunterbrook releases a bearish report alleging that Hims & Hers sells knockoff GLP-1 weight loss drugs and relies on a sing...

Core News & Articles

https://www.bloomberg.com/news/articles/2024-06-27/novo-will-limit-wegovy-s-china-launch-to-avoid-global-disruption?utm_content...